Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Sorrento Therapeutics, a San Diego-Nanjing company...
United Biopharma, a Taiwan based pharmaceutical company,...
Loncar Investments has launched its Loncar China...
Loncar launched its China BioPharma ETF, a fund that...
China's C-Bridge Capital in-licensed China rights to...
Taiwan Liposome Company (TLC) completed a $27.3 million...
Sorrento Therapeutics, a San Diego-Nanjing-Suzhou...
Apexigen, a Bay Area clinical-stage biopharma, closed a...
Shanghai's HanBio Therapeutics raised $40 million in...
Deals and Financings
CFIUS, a US committee set up to...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
